✅ALGERNON PHARMACEUTICALS EXPLODES OVER 200% SINCE MY ALERT ✅ – RICH TV LIVE – APRIL 13, 2020 – Algernon Pharmaceuticals Inc (CSE:AGN) (OTCQB:AGNPF) said Monday it has received positive feedback from the US Food and Drug Administration regarding the company’s plans to conduct a phase 2 COVID-19 clinical trial using its repurposed drug NP-120, known as Ifenprodil.

What’s going on guys this is rich from mr. villi so i had to show you guys this i brought you this at 15 cents aldrin in pharmaceuticals i brought it to at 15 cents it was up 72 percent today ilona monster day for algernon pharmaceuticals in canada and look at the american side up 69% today alone and let’s see why algernon receives positive feedback from us fda

For if in protocol covin 19 human trial appoints us ambassador howard goodman to advisory board this is the breaking news agn in canada a gw in germany and a gnp f in america a clinical stage from a suitable development company is pleased to announce it has received positive feedback from the us food and drug administration the fda regarding the company’s plans to

Conduct a phase two cova 19 clinical trial using its repurposed drug np – 120 – proto based on the feedback the company plans to submit as soon as possible an investigational new drug ind application to the fda to conduct a phase two clinical trial with – proto as a therapy for patients who experience respiratory complications as a result of contracting kovat 19 we

Are very pleased with the expedited response we receive from the fda on our pre ind application said christopher j monroe ceo of algernon this is the first time i’ve been proto has been presented to the fda in a formal process and the response was very encouraging you think the stock exploded guys it exploded and of course we brought it to you guys first it’s what

See also  3 BEST APPS TO EARN AND SAVE MONEY! (Earny, Acorns & Qapital)

We do is what we do best and we’ve done it again in fact i got the evidence right here should we get should we get into the evidence right here let’s do this rich tv5 take a look at this one month ago and you know i always tell you guys to invest in the best because the best is blessed i got to give it out to dylan fraser man he brought me this pic and i have a

Feeling it’s gonna blow allergen pharmaceuticals at fifteen cents up 66% on friday and they’ve got some big news guys symbol in america ag npf symbol in canada a gn both the american and canadian symbol exploded on friday and the symbol in frankfurt germany a gw another potential big winner another big winner it’s true check this out look at the big news this came

Out after market after market on friday allergen algernon pharmaceuticals inc agn in canada a gw in frankfurt a gnp f in america a clinical stage from the circle development company is pleased to announce it will set aside some of its np 120 – pro dill drug supply from its planned phase two study of idle pathak fibrosis and chronic cough to make it available on a

Compassionate use basis to physicians and their patients with the most serious cases of coronavirus you know as soon as you put that word in a press release you know that people are going to pay attention the decision was made based on the results of an independent study of eyghon proto which showed a 40% improvement in mortality and significantly reduced acute lung

Injury aoi in a recent h5n1 animal study h5n1 is one of the most lethal form of influenza known with a 53% mortality rate since i fin pro dell is an already approved drug with a no.1 safety history it can be safely administered to patients without additional preclinical testing i think this is huge news is breaking news if we see a similar response in coronavirus

See also  5 Stocks Under To Watch!

Patients as seen in the h5n1 animal study a far more lethal of influenza we believe that patient outcomes should be significantly improved said christopher j morneau ceo of algernon algernon rica welcomes contact from the health organizations and physicians globally to learn more about np – 120 – proto this is huge news management believe that the np – 120 – proto

Is a possible treatment for kovat – 19 coronavirus is based on historical animal studies and not on human trials you only find these out first here a rich tv live this is where you get the picks folks you get the picks first from your boy at rich tv live it’s true we bring you the winners first not second not third not v not 55th first it’s true what do you think

About what do you think about this stock i’ll turn on pharmaceuticals np – 120 – proto is an n methanol d aspirate and dma receptor glutamate receptor antagonist specifically targeting the nmda – type subunit to be blue – and b – prone l also exhibits anga nest activity for the sigma-1 receptor a tariff own protein up regulated during endoplasmic reticulum stress

Although the anti fry broke fibrotic activity of eyghon proto in ipf is not known recent studies have suggested a link between both receptors and pathways a soda associated with fibrosis glutamate glu is the main exit exit ettore neurotransmitter which acts as glutamate receptors in the central nervous system otherwise known as cns but over activation of these

Receptors can cause several damages to neural cells including death recent studies show that the glutamate a guinness and methanol d aspirin and mda can trigger acute lung injury a li a lies directly in direct injury to alveolar epithelial cells and capala capillary and dolphin l cell causing diffuse pulmonary interst idol and alveolar and demma an acute hypoxic

See also  WonderFi to Acquire Crypto APIs, Leading Crypto and Blockchain Market Data Provider

Respiratory respiration failure a li is characterized by reduced lung volume and compliance and imbalance of the ventilation perfusion ratio inducing hypoxemia and respiratory distress and it’s severe stage oxygen index 200 known as acute respiratory distress syndrome or a rds and – 120 – protal brand name sarah cow was initially developed by santa fe in the 1990s

In the french and japanese markets for the treatment of circulatory disorders the drug is generous sized and sold in japan algernon has phil filed with new intellectual property rights for np – 120 – proto for the treatment of respiratory disease this is absolutely about 12 cents stock in america 15 cents in canada nobody even knows and these guys could potentially

Be helping the entire world elgin in pharmaceuticals is a clinical stage pharmaceutical development company focused on advancing its lead compounds for non-alcoholic steve-o hepatitis neckla otherwise known as na sh nats i think you guys get the head we brought it to you first like usual and it blew up 200% we did it again algernon pharmaceuticals agn in canada

A gnp f in america huge day monster day i brought it to you five weeks ago at 15 cents in canada 12 cents in america another 200% gainer you’re not winning you’re not watching we bring in the winners and we bring them to you first put on your watches put on your radar this bad baby is on fire your boy richard mr. beale ivan um oh peace

Transcribed from video
✅ALGERNON PHARMACEUTICALS EXPLODES OVER 200% SINCE MY ALERT ✅ By RICH TV LIVEliveBroadcastDetails{isLiveNowfalsestartTimestamp2020-04-13T215321+0000endTimestamp2020-04-13T220245+0000}

Scroll to top